Literature DB >> 10834846

Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1.

M J Herron1, C M Nelson, J Larson, K R Snapp, G S Kansas, J L Goodman.   

Abstract

Human granulocytic ehrlichiosis (HGE) is a febrile tick-borne illness caused by a recently discovered intracellular bacterium remarkable for its tropism for professionally phagocytic neutrophils. Monoclonal antibodies against the P-selectin binding domain of the leukocyte P-selectin glycoprotein ligand, PSGL-1, prevented HGE cell binding and infection, as did enzymatic digestion of PSGL-1. Furthermore, simultaneous neoexpression in nonsusceptible cells of complementary DNAs for both PSGL-1 and its modifying alpha-(1,3) fucosyltransferase, Fuc-TVII, allowed binding and infection by HGE. Thus, the HGE bacterium specifically bound to fucosylated leukocyte PSGL-1. Selectin mimicry is likely central to the organism's unique ability to target and infect neutrophils.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834846     DOI: 10.1126/science.288.5471.1653

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  47 in total

1.  Fucosylation enhances colonization of ticks by Anaplasma phagocytophilum.

Authors:  Joao H F Pedra; Sukanya Narasimhan; Dubravko Rendić; Kathleen DePonte; Lesley Bell-Sakyi; Iain B H Wilson; Erol Fikrig
Journal:  Cell Microbiol       Date:  2010-03-19       Impact factor: 3.715

Review 2.  Insight into a conserved lifestyle: protein-carbohydrate adhesion strategies of vector-borne pathogens.

Authors:  Rhoel R Dinglasan; Marcelo Jacobs-Lorena
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Jason A Carlyon; Ji-Lian Cai; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 4.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Rickettsial entry into host cells: finding the keys to unlock the doors.

Authors:  Guy H Palmer; Susan M Noh
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

Review 6.  Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Vet Parasitol       Date:  2009-09-19       Impact factor: 2.738

7.  Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation.

Authors:  Jafar Mahdavi; Berit Sondén; Marina Hurtig; Farzad O Olfat; Lina Forsberg; Niamh Roche; Jonas Angstrom; Thomas Larsson; Susann Teneberg; Karl-Anders Karlsson; Siiri Altraja; Torkel Wadström; Dangeruta Kersulyte; Douglas E Berg; Andre Dubois; Christoffer Petersson; Karl-Eric Magnusson; Thomas Norberg; Frank Lindh; Bertil B Lundskog; Anna Arnqvist; Lennart Hammarström; Thomas Borén
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

8.  Glycosylation of Anaplasma marginale major surface protein 1a and its putative role in adhesion to tick cells.

Authors:  Jose C Garcia-Garcia; José de la Fuente; Gianna Bell-Eunice; Edmour F Blouin; Katherine M Kocan
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis.

Authors:  M Bayard-Mc Neeley; A Bansal; I Chowdhury; G Girao; C B Small; K Seiter; J Nelson; D Liveris; I Schwartz; D F Mc Neeley; G P Wormser; M E Aguero-Rosenfeld
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

10.  Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection.

Authors:  Jason A Carlyon; Dalia Abdel-Latif; Marc Pypaert; Paige Lacy; Erol Fikrig
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.